Logo image of BRM.CA

BIOREM INC (BRM.CA) Stock Fundamental Analysis

Canada - TSX-V:BRM - CA09068G1046 - Common Stock

2.16 CAD
+0.01 (+0.47%)
Last: 11/7/2025, 7:00:00 PM
Fundamental Rating

7

Taking everything into account, BRM scores 7 out of 10 in our fundamental rating. BRM was compared to 24 industry peers in the Commercial Services & Supplies industry. BRM gets an excellent profitability rating and is at the same time showing great financial health properties. BRM is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, BRM could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

BRM had positive earnings in the past year.
BRM had a positive operating cash flow in the past year.
In the past 5 years BRM has always been profitable.
Each year in the past 5 years BRM had a positive operating cash flow.
BRM.CA Yearly Net Income VS EBIT VS OCF VS FCFBRM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M 3M 4M

1.2 Ratios

BRM has a Return On Assets of 11.60%. This is amongst the best in the industry. BRM outperforms 91.67% of its industry peers.
With an excellent Return On Equity value of 28.73%, BRM belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
BRM has a Return On Invested Capital of 25.39%. This is amongst the best in the industry. BRM outperforms 100.00% of its industry peers.
BRM had an Average Return On Invested Capital over the past 3 years of 25.13%. This is significantly above the industry average of 7.09%.
The last Return On Invested Capital (25.39%) for BRM is above the 3 year average (25.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.6%
ROE 28.73%
ROIC 25.39%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
BRM.CA Yearly ROA, ROE, ROICBRM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

The Profit Margin of BRM (8.20%) is better than 83.33% of its industry peers.
BRM's Profit Margin has improved in the last couple of years.
BRM's Operating Margin of 11.72% is fine compared to the rest of the industry. BRM outperforms 79.17% of its industry peers.
BRM's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 26.79%, BRM is in line with its industry, outperforming 54.17% of the companies in the same industry.
In the last couple of years the Gross Margin of BRM has grown nicely.
Industry RankSector Rank
OM 11.72%
PM (TTM) 8.2%
GM 26.79%
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
BRM.CA Yearly Profit, Operating, Gross MarginsBRM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRM is creating value.
Compared to 1 year ago, BRM has more shares outstanding
The number of shares outstanding for BRM has been reduced compared to 5 years ago.
Compared to 1 year ago, BRM has an improved debt to assets ratio.
BRM.CA Yearly Shares OutstandingBRM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BRM.CA Yearly Total Debt VS Total AssetsBRM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 3.80 indicates that BRM is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.80, BRM belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
The Debt to FCF ratio of BRM is 0.71, which is an excellent value as it means it would take BRM, only 0.71 years of fcf income to pay off all of its debts.
BRM has a Debt to FCF ratio of 0.71. This is amongst the best in the industry. BRM outperforms 95.83% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that BRM is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.23, BRM belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 0.71
Altman-Z 3.8
ROIC/WACC3.4
WACC7.46%
BRM.CA Yearly LT Debt VS Equity VS FCFBRM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 1.73 indicates that BRM should not have too much problems paying its short term obligations.
BRM's Current ratio of 1.73 is fine compared to the rest of the industry. BRM outperforms 66.67% of its industry peers.
A Quick Ratio of 1.60 indicates that BRM should not have too much problems paying its short term obligations.
BRM has a Quick ratio of 1.60. This is in the better half of the industry: BRM outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.6
BRM.CA Yearly Current Assets VS Current LiabilitesBRM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

5

3. Growth

3.1 Past

The earnings per share for BRM have decreased strongly by -27.86% in the last year.
BRM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.08% yearly.
BRM shows a small growth in Revenue. In the last year, the Revenue has grown by 4.09%.
The Revenue has been growing by 12.63% on average over the past years. This is quite good.
EPS 1Y (TTM)-27.86%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%9.59%
Revenue 1Y (TTM)4.09%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-28.66%

3.2 Future

Based on estimates for the next years, BRM will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.71% on average per year.
The Revenue is expected to grow by 7.57% on average over the next years.
EPS Next Y-5.26%
EPS Next 2Y14.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.08%
Revenue Next 2Y7.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRM.CA Yearly Revenue VS EstimatesBRM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
BRM.CA Yearly EPS VS EstimatesBRM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.71, which indicates a correct valuation of BRM.
91.67% of the companies in the same industry are more expensive than BRM, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.83, BRM is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.39, the valuation of BRM can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 91.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.68, BRM is valued rather cheaply.
Industry RankSector Rank
PE 12.71
Fwd PE 8.39
BRM.CA Price Earnings VS Forward Price EarningsBRM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BRM is valued cheaper than 91.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 91.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.86
EV/EBITDA 5.99
BRM.CA Per share dataBRM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

BRM has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BRM's earnings are expected to grow with 14.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.71%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BRM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BIOREM INC

TSX-V:BRM (11/7/2025, 7:00:00 PM)

2.16

+0.01 (+0.47%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-26 2025-08-26
Earnings (Next)11-26 2025-11-26
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners2%
Ins Owner ChangeN/A
Market Cap34.71M
Revenue(TTM)38.36M
Net Income(TTM)3.14M
Analysts84.44
Price Target3.57 (65.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-18.18%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.47%
Valuation
Industry RankSector Rank
PE 12.71
Fwd PE 8.39
P/S 0.9
P/FCF 7.86
P/OCF 7.29
P/B 3.17
P/tB 3.17
EV/EBITDA 5.99
EPS(TTM)0.17
EY7.87%
EPS(NY)0.26
Fwd EY11.92%
FCF(TTM)0.27
FCFY12.73%
OCF(TTM)0.3
OCFY13.72%
SpS2.39
BVpS0.68
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.61
Profitability
Industry RankSector Rank
ROA 11.6%
ROE 28.73%
ROCE 33.52%
ROIC 25.39%
ROICexc 59.12%
ROICexgc 59.12%
OM 11.72%
PM (TTM) 8.2%
GM 26.79%
FCFM 11.52%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
ROICexc(3y)41.23%
ROICexc(5y)N/A
ROICexgc(3y)41.23%
ROICexgc(5y)N/A
ROCE(3y)33.17%
ROCE(5y)30.97%
ROICexgc growth 3Y-30.69%
ROICexgc growth 5YN/A
ROICexc growth 3Y-30.69%
ROICexc growth 5YN/A
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
F-Score5
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 0.71
Debt/EBITDA 0.49
Cap/Depr 60.74%
Cap/Sales 0.9%
Interest Coverage 250
Cash Conversion 94.04%
Profit Quality 140.5%
Current Ratio 1.73
Quick Ratio 1.6
Altman-Z 3.8
F-Score5
WACC7.46%
ROIC/WACC3.4
Cap/Depr(3y)93.69%
Cap/Depr(5y)79.96%
Cap/Sales(3y)1.3%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.86%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%9.59%
EPS Next Y-5.26%
EPS Next 2Y14.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.09%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-28.66%
Revenue Next Year1.08%
Revenue Next 2Y7.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.95%
EBIT growth 3Y23.48%
EBIT growth 5YN/A
EBIT Next Year19.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y370.17%
FCF growth 3Y-3.66%
FCF growth 5Y6.73%
OCF growth 1Y533.73%
OCF growth 3Y-0.86%
OCF growth 5Y7.83%

BIOREM INC / BRM.CA FAQ

What is the fundamental rating for BRM stock?

ChartMill assigns a fundamental rating of 7 / 10 to BRM.CA.


What is the valuation status for BRM stock?

ChartMill assigns a valuation rating of 8 / 10 to BIOREM INC (BRM.CA). This can be considered as Undervalued.


How profitable is BIOREM INC (BRM.CA) stock?

BIOREM INC (BRM.CA) has a profitability rating of 9 / 10.


How financially healthy is BIOREM INC?

The financial health rating of BIOREM INC (BRM.CA) is 8 / 10.


What is the expected EPS growth for BIOREM INC (BRM.CA) stock?

The Earnings per Share (EPS) of BIOREM INC (BRM.CA) is expected to decline by -5.26% in the next year.